drugset / Trial / NCT01852591
Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
NaSingle-groupOpen-label
Summary
There is no study hypothesis. The purpose of this study is to see if the Pneumococcal conjugate vaccine (PCV13), when administered before and early after an autologous peripheral stem cell transplant will induce an immune response.
Timeline
- Start
- 2013-02
- Primary completion
- 2015-02
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prevnar 13 | Vaccine | 0.5 ml | — |